LV10270B - Novel pharmacological compounds - Google Patents

Novel pharmacological compounds

Info

Publication number
LV10270B
LV10270B LVP-93-856A LV930856A LV10270B LV 10270 B LV10270 B LV 10270B LV 930856 A LV930856 A LV 930856A LV 10270 B LV10270 B LV 10270B
Authority
LV
Latvia
Prior art keywords
pharmacological compounds
novel pharmacological
compounds
novel
chem
Prior art date
Application number
LVP-93-856A
Other languages
English (en)
Other versions
LV10270A (lv
Inventor
Tomas B Rje Alminger
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Hokan Sigurd Larsson
Original Assignee
H Ssle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Ssle Ab filed Critical H Ssle Ab
Publication of LV10270A publication Critical patent/LV10270A/xx
Publication of LV10270B publication Critical patent/LV10270B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
LVP-93-856A 1985-10-29 1993-06-30 Novel pharmacological compounds LV10270B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8505112A SE8505112D0 (sv) 1985-10-29 1985-10-29 Novel pharmacological compounds
PCT/SE1986/000493 WO1987002668A1 (en) 1985-10-29 1986-10-28 Novel pharmacological compounds

Publications (2)

Publication Number Publication Date
LV10270A LV10270A (lv) 1994-10-20
LV10270B true LV10270B (en) 1995-04-20

Family

ID=20361960

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-856A LV10270B (en) 1985-10-29 1993-06-30 Novel pharmacological compounds

Country Status (31)

Country Link
US (1) US5021433A (xx)
EP (2) EP0221041A3 (xx)
JP (2) JPH0780874B2 (xx)
KR (1) KR950009858B1 (xx)
CN (1) CN1022487C (xx)
AT (1) ATE79619T1 (xx)
AU (1) AU598491B2 (xx)
CS (1) CS272767B2 (xx)
DD (1) DD252375A5 (xx)
DE (1) DE3686483T2 (xx)
DK (1) DK320587A (xx)
EG (1) EG17753A (xx)
ES (1) ES2051696T3 (xx)
FI (1) FI91151C (xx)
GR (1) GR3006177T3 (xx)
HU (1) HU198474B (xx)
IE (1) IE59167B1 (xx)
IL (1) IL80437A0 (xx)
IS (1) IS1564B (xx)
JO (1) JO1502B1 (xx)
LT (1) LTIP1681A (xx)
LV (1) LV10270B (xx)
MY (1) MY101791A (xx)
NO (1) NO171365C (xx)
NZ (1) NZ218028A (xx)
PH (1) PH25319A (xx)
PL (1) PL150240B1 (xx)
PT (1) PT83647B (xx)
SE (1) SE8505112D0 (xx)
WO (1) WO1987002668A1 (xx)
ZA (1) ZA867716B (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222495A (en) * 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
EP0436025A4 (en) * 1988-09-20 1991-09-11 Hisamitsu Pharmaceutical Co. Inc. Novel dibenz b,e)oxepin derivatives
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
EG19302A (en) * 1988-12-22 1994-11-30 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
CA2083606C (en) * 1990-06-20 2001-08-21 Arne Elof Brandstrom Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
WO1995032957A1 (en) * 1994-05-27 1995-12-07 Astra Aktiebolag Novel ethoxycarbonyloxymethyl derivatives of substituted benzimidazoles
MXPA01001464A (es) 1998-08-10 2002-05-08 Partnership Of Michael E Garst Precursores de inhibidores de la bomba de protones.
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
EP1334971A4 (en) * 2000-10-12 2004-05-12 Takeda Chemical Industries Ltd BENZIMIDAZOLE COMPOUNDS, METHOD FOR THE PRODUCTION AND USE THEREOF
US20040248941A1 (en) * 2001-09-25 2004-12-09 Keiji Kamiyama Benzimidazone compound, process for producing the same, and use thereof
DE60328603D1 (de) * 2002-06-14 2009-09-10 Takeda Pharmaceutical Prodrugs von imidazol-derivaten, zur verwendung als protonenpumpen-hemmer zur behandlung von z.b. peptischen magengeschwüren
ATE323695T1 (de) * 2002-07-19 2006-05-15 Winston Pharmaceuticals Llc Benzimidazolderivative und ihre verwendung als prodrugs für protonenpumpenhemmer
EP1534278A4 (en) 2002-08-01 2006-09-06 Nitromed Inc NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
WO2005039640A1 (en) * 2003-10-03 2005-05-06 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
CA2556756A1 (en) * 2004-02-18 2005-09-09 Allergan, Inc. Compositions comprising prodrugs of proton pump inhibitors
JP2007523164A (ja) * 2004-02-18 2007-08-16 アラーガン、インコーポレイテッド プロトンポンプインヒビターに関連する化合物の静脈内投与のための方法および組成物
CA2561700A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US7176319B2 (en) 2004-04-28 2007-02-13 Hetero Drugs Limited Process for substituted sulfoxides
PT1748998E (pt) 2004-05-28 2010-03-24 Hetero Drugs Ltd Novo processo de síntese estereoselectiva de sulfóxidos de benzimidazol
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
JP5457830B2 (ja) * 2006-04-03 2014-04-02 オディディ，イサ オルガノゾル被膜を含む制御放出送達デバイス
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US20100317689A1 (en) * 2006-09-19 2010-12-16 Garst Michael E Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
US20080103169A1 (en) 2006-10-27 2008-05-01 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
WO2009105568A1 (en) 2008-02-20 2009-08-27 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
WO2011084848A2 (en) 2010-01-07 2011-07-14 Alkermes, Inc. Prodrugs of heteraromatic compounds

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR320097A (fr) * 1902-04-01 1902-12-01 Betts Perfectionnements dans et relatifs au raffinage électrolytique du plomb et des alliages de plomb
FR1474663A (fr) * 1966-04-06 1967-03-24 Electrolyt Zinc Australasia Procédé d'extraction de métaux
US4026776A (en) * 1970-12-02 1977-05-31 Mitsui Mining & Smelting Co., Ltd. Method for producing high purity lead
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
US4045564A (en) * 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
US3960681A (en) * 1974-02-21 1976-06-01 Mitsui Mining & Smelting Co., Ltd. Method for producing electrolytic high purity lead using large-sized electrodes
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
NZ181123A (en) * 1975-06-30 1979-12-11 Univ Melbourne Treatment of mineralcontaining materials with an acid in the presence of fluoride ion
US3972790A (en) * 1975-09-26 1976-08-03 Uop Inc. Production of metallic lead
IN148930B (xx) * 1977-09-19 1981-07-25 Hoffmann La Roche
US4189461A (en) * 1977-11-30 1980-02-19 Kennecott Copper Corporation Metal leaching from concentrates using nitrogen dioxide in acids
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
FR2446863A1 (fr) * 1979-01-22 1980-08-14 Uop Inc Procede perfectionne de recuperation de plomb
FR2453906A1 (fr) * 1979-04-12 1980-11-07 Uop Inc Procede de preparation hydrometallurgique de plomb a l'aide d'une extraction par voie electrochimique
US4229271A (en) * 1979-05-24 1980-10-21 Rsr Corporation Method of recovering lead values from battery sludge
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
FR2505876A1 (en) * 1981-05-12 1982-11-19 Noual Patrick Selective winning of lead from sulphide ores - by leaching with hot aq. hydro:fluorosilicic acid soln. contg. hydrogen peroxide and air so only lead is dissolved
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
US4500398A (en) * 1984-06-20 1985-02-19 The United States Of America As Represented By The Secretary Of The Interior Production of lead from sulfides
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
ZA856671B (en) * 1984-09-24 1986-04-30 Upjohn Co N-substituted derivatives of 2-(pyridylaklenesulfinyl)benzimidazoles as gastric antisecretory agents

Also Published As

Publication number Publication date
IS3156A7 (is) 1987-04-30
JO1502B1 (en) 1989-01-25
NZ218028A (en) 1990-02-26
IL80437A0 (en) 1987-01-30
GR3006177T3 (xx) 1993-06-21
EP0233284A1 (en) 1987-08-26
IE862805L (en) 1987-04-29
DD252375A5 (de) 1987-12-16
CN1022487C (zh) 1993-10-20
US5021433A (en) 1991-06-04
JPH0780874B2 (ja) 1995-08-30
JPS63501151A (ja) 1988-04-28
DK320587D0 (da) 1987-06-24
CN86107595A (zh) 1987-07-08
NO171365C (no) 1993-03-03
ES2051696T3 (es) 1994-07-01
EG17753A (en) 1991-12-30
DK320587A (da) 1987-06-24
NO872686D0 (no) 1987-06-26
FI91151C (sv) 1994-05-25
EP0233284B1 (en) 1992-08-19
WO1987002668A1 (en) 1987-05-07
PT83647A (en) 1986-11-01
CS782686A2 (en) 1990-05-14
JPH07188216A (ja) 1995-07-25
IE59167B1 (en) 1994-01-12
FI91151B (fi) 1994-02-15
HU198474B (en) 1989-10-30
MY101791A (en) 1992-01-31
DE3686483T2 (de) 1993-02-04
CS272767B2 (en) 1991-02-12
EP0221041A2 (en) 1987-05-06
ZA867716B (en) 1987-05-27
HUT43843A (en) 1987-12-28
KR950009858B1 (ko) 1995-08-29
PL150240B1 (en) 1990-05-31
DE3686483D1 (de) 1992-09-24
PL262105A1 (en) 1988-08-18
ATE79619T1 (de) 1992-09-15
AU598491B2 (en) 1990-06-28
FI872864A0 (fi) 1987-06-29
AU6542986A (en) 1987-05-19
NO872686L (no) 1987-06-26
FI872864A (fi) 1987-06-29
KR870700620A (ko) 1987-12-30
NO171365B (no) 1992-11-23
LTIP1681A (en) 1995-09-25
IS1564B (is) 1994-12-13
LV10270A (lv) 1994-10-20
JPH0826014B2 (ja) 1996-03-13
SE8505112D0 (sv) 1985-10-29
EP0221041A3 (en) 1987-10-28
PT83647B (pt) 1989-05-31
PH25319A (xx) 1991-04-30

Similar Documents

Publication Publication Date Title
EG17753A (en) Novel pharmacological compounds
MY101784A (en) Novel pharmacological compounds
SE8700499L (sv) Nya farmakologiskt aktiva foreningar
EP0564739A3 (xx)
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
SE8404065D0 (sv) Novel biologically active compounds
EP0321968A3 (en) Compounds active on the cardiovascular system
SE8600658D0 (sv) Novel composition of matter
JO1531B1 (en) New near-compounds
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
GR850484B (xx)